RxDoctor Payments Data

Kurt Martin, MD

Pediatrics · Carbondale, ILNPI 1164535365

Payments from drug & device makers

$1,462in general payments, 2019–2025

Across 95 payments — averaging $15.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$582
  • Pfizer$239
  • Amgen$180
  • EMD Serono, Inc.$101
  • Dexcom, Inc.$96
  • Lilly USA, LLC$81
  • plus $183 from 7 others

What the payments were for

  • Food & beverage$1,462100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,462 in reported general payments places this provider in the 90th percentile of 2,058 pediatrics providers in Illinois.

See all pediatrics providers in Illinois

Medicare billing

Part B allowed, 2024
$14,842
Medicare patients
38
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide147$191,384
EliquisApixaban172$172,718
JardianceEmpagliflozin182$164,619
MounjaroTirzepatide65$91,282
TrulicityDulaglutide59$74,440
RybelsusSemaglutide39$70,813
JanuviaSitagliptin Phosphate85$67,121
BiktarvyBictegrav/Emtricit/Tenofov Ala14$62,914
LinzessLinaclotide93$59,061
XifaxanRifaximin12$50,263
Repatha SureclickEvolocumab53$46,689
TradjentaLinagliptin30$29,343
FarxigaDapagliflozin Propanediol22$21,343
MyrbetriqMirabegron39$20,592
XareltoRivaroxaban11$17,271

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$65$262,196186 claims
Boehringer IngelheimJardiance, Tradjenta$24$193,963212 claims
PfizerEliquis$239$172,718172 claims
Lilly USA, LLCMounjaro, Trulicity$81$165,721124 claims
AbbVieLinzess, Synthroid$582$62,994157 claims
AstraZenecaFarxiga$26$21,34322 claims
GSKTrelegy Ellipta, Arnuity Ellipta$28$17,71429 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,058 pediatrics providers in Illinois.

Other pediatrics in Carbondale

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →